FLT3 inhibitors as MRD-guided salvage treatment for molecular failure in FLT3 mutated AML. Othman J, Potter N, Mokretar K, Taussig D, et al. Leukemia 2023;37:2066-2072.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Othman J, Potter N, Mokretar K, Taussig D, et al. FLT3 inhibitors as MRD-guided salvage treatment for molecular failure in FLT3 mutated AML. Leukemia 2023;37:2066-2072.
PMID: 37558736